RANDAL MORGAN: Open Payments
NPI 1083764294 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 18 payments from 6 companies in 2025. Trend: 2023 $312 · 2024 $287 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $150 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Radius Health, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $55 |
| Astellas Pharma US Inc | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: ZURZUVAE, Tymlos, MYFEMBREE, ZEPBOUND, GEMTESA, Veozah, EVENITY.
Industry payments across TX — which companies pay providers there.
